NECTIN3
gene geneOn this page
Also known as nectin-3PPR3PVRR3DKFZP566B0846CDw113CD113
Summary
NECTIN3 (nectin cell adhesion molecule 3, HGNC:17664) is a protein-coding gene on chromosome 3q13.13, encoding Nectin-3 (Q9NQS3). Cell adhesion molecule that promotes cell-cell adhesion through heterophilic trans-interactions with nectins-like or other nectins, such as trans-interaction with NECTIN2 at Sertoli-spermatid junctions.
This gene encodes a member of the nectin family of proteins, which function as adhesion molecules at adherens junctions. This family member interacts with other nectin-like proteins and with afadin, a filamentous actin-binding protein involved in the regulation of directional motility, cell proliferation and survival. This gene plays a role in ocular development involving the ciliary body. Mutations in this gene are believed to result in congenital ocular defects. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 25945 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_015480
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17664 |
| Approved symbol | NECTIN3 |
| Name | nectin cell adhesion molecule 3 |
| Location | 3q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | nectin-3, PPR3, PVRR3, DKFZP566B0846, CDw113, CD113 |
| Ensembl gene | ENSG00000177707 |
| Ensembl biotype | protein_coding |
| OMIM | 607147 |
| Entrez | 25945 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 10 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000319792, ENST00000461477, ENST00000470618, ENST00000478327, ENST00000481766, ENST00000485303, ENST00000485506, ENST00000486596, ENST00000488016, ENST00000491525, ENST00000493615, ENST00000911298, ENST00000911299
RefSeq mRNA: 3 — MANE Select: NM_015480
NM_001243286, NM_001243288, NM_015480
CCDS: CCDS2957, CCDS58842, CCDS58843
Canonical transcript exons
ENST00000485303 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001240523 | 111118656 | 111118952 |
| ENSE00001656135 | 111126184 | 111126335 |
| ENSE00001847483 | 111071816 | 111072177 |
| ENSE00001901574 | 111133635 | 111137560 |
| ENSE00002019335 | 111122121 | 111122238 |
| ENSE00003469533 | 111112030 | 111112371 |
Expression profiles
Bgee: expression breadth ubiquitous, 238 present calls, max score 94.19.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.0976 / max 267.6819, expressed in 1465 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 37856 | 10.6475 | 1427 |
| 37857 | 0.8517 | 429 |
| 37853 | 0.5309 | 316 |
| 37852 | 0.4218 | 229 |
| 37854 | 0.2292 | 81 |
| 37858 | 0.2057 | 100 |
| 37855 | 0.1849 | 43 |
| 37859 | 0.0258 | 3 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| stromal cell of endometrium | CL:0002255 | 94.19 | gold quality |
| sperm | CL:0000019 | 92.67 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.36 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.28 | gold quality |
| male germ cell | CL:0000015 | 90.76 | gold quality |
| placenta | UBERON:0001987 | 90.11 | gold quality |
| left testis | UBERON:0004533 | 89.78 | gold quality |
| rectum | UBERON:0001052 | 89.77 | gold quality |
| right testis | UBERON:0004534 | 89.54 | gold quality |
| testis | UBERON:0000473 | 89.27 | gold quality |
| jejunal mucosa | UBERON:0000399 | 88.81 | gold quality |
| duodenum | UBERON:0002114 | 88.27 | gold quality |
| cortical plate | UBERON:0005343 | 87.28 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.99 | gold quality |
| adrenal tissue | UBERON:0018303 | 86.88 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.65 | gold quality |
| colonic epithelium | UBERON:0000397 | 85.41 | gold quality |
| secondary oocyte | CL:0000655 | 84.69 | gold quality |
| colonic mucosa | UBERON:0000317 | 83.79 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 83.31 | gold quality |
| ventricular zone | UBERON:0003053 | 82.63 | gold quality |
| stomach | UBERON:0000945 | 80.97 | gold quality |
| thyroid gland | UBERON:0002046 | 80.81 | gold quality |
| liver | UBERON:0002107 | 80.65 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 80.56 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 80.46 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 80.38 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 80.27 | gold quality |
| oocyte | CL:0000023 | 80.21 | gold quality |
| right lobe of liver | UBERON:0001114 | 79.92 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-81608 | yes | 18.51 |
| E-ENAD-27 | yes | 11.11 |
| E-GEOD-83139 | yes | 10.06 |
| E-ANND-3 | yes | 6.30 |
| E-ENAD-21 | no | 31.22 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): FOXO1
miRNA regulators (miRDB)
197 targeting NECTIN3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
Literature-anchored findings (GeneRIF, showing 9)
- Data suggest that expression of nectin-3 is up-regulated in eutopic endometrium of patients with endometriosis as compared with control subjects and up-regulated in all endometriotic lesions investigated compared with eutopic endometrium. (PMID:22926846)
- Nectin-3 trans-interacts with Nectin-2 to promote lymphocyte and monocyte extravasation. (PMID:24116228)
- Nectin-3 is associated with the formation of cell junctions and be a putative suppressor molecule to the invasion of breast cancer cells. (PMID:24386110)
- Expression of nectin-3 in pancreatic cancer can be a prognostic factor. (PMID:25690753)
- PVRL3 is a physiologically relevant binding partner that can serve as a target for the prevention of TcdB-induced cytotoxicity in C. difficile infection. (PMID:26038560)
- Data suggest that 3 independent regions of TcdB (Clostridium difficile toxin B; 1372-1493, 1493-1848, 1851-2366) contribute to binding and entry of TcdB into mammalian cells; residues 1372-1493 are sufficient for interaction with PVRL3. (PMID:26602083)
- Nectin-3 mutation in men with severe teratospermia (PMID:28689229)
- Nectin-3 expression was associated with ovarian cancer, and a greater expression level of nectin-3 was related to poor overall survival. (PMID:30469078)
- Loss of nectin-3 expression as a marker of tumor aggressiveness in pancreatic neuroendocrine tumor. (PMID:31855317)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nectin3b | ENSDARG00000006604 |
| danio_rerio | ENSDARG00000103638 | |
| mus_musculus | Nectin3 | ENSMUSG00000022656 |
| rattus_norvegicus | Nectin3 | ENSRNOG00000002176 |
| drosophila_melanogaster | Fas3 | FBGN0000636 |
Paralogs (14): PVR (ENSG00000073008), CD200 (ENSG00000091972), CADM4 (ENSG00000105767), CRTAM (ENSG00000109943), NECTIN1 (ENSG00000110400), NECTIN2 (ENSG00000130202), NECTIN4 (ENSG00000143217), CD226 (ENSG00000150637), CADM3 (ENSG00000162706), SMAGP (ENSG00000170545), CADM2 (ENSG00000175161), TIGIT (ENSG00000181847), CADM1 (ENSG00000182985), NCR3 (ENSG00000204475)
Protein
Protein identifiers
Nectin-3 — Q9NQS3 (reviewed: Q9NQS3)
Alternative names: CDw113, Nectin cell adhesion molecule 3, Poliovirus receptor-related protein 3
All UniProt accessions (6): Q9NQS3, C9IZE6, C9J795, C9JMW3, H7C4L0, H7C5G5
UniProt curated annotations — full annotation on UniProt →
Function. Cell adhesion molecule that promotes cell-cell adhesion through heterophilic trans-interactions with nectins-like or other nectins, such as trans-interaction with NECTIN2 at Sertoli-spermatid junctions. Trans-interaction with PVR induces activation of CDC42 and RAC small G proteins through common signaling molecules such as SRC and RAP1. Induces endocytosis-mediated down-regulation of PVR from the cell surface, resulting in reduction of cell movement and proliferation. Involved in axon guidance by promoting contacts between the commissural axons and the floor plate cells. Also involved in the formation of cell-cell junctions, including adherens junctions and synapses. Promotes formation of checkerboard-like cellular pattern of hair cells and supporting cells in the auditory epithelium via heterophilic interaction with NECTIN1: NECTIN1 is present in the membrane of hair cells and associates with NECTIN3 on supporting cells, thereby mediating heterotypic adhesion between these two cell types. Plays a role in the morphology of the ciliary body.
Subunit / interactions. Cis- and trans-homodimer. Can form trans-heterodimers with NECTIN1, NECTIN2, PVR, IGSF4B/Necl-1 and with IGSF4. Interaction between NECTIN1 and NECTIN3 on the pre- and postsynaptic sites, respectively, initiates the formation of puncta adherentia junctions between axons and dendrites. Interacts (via Cytoplasmic domain) with AFDN, providing a connection with the actin cytoskeleton. Binds with low affinity to TIGIT. (Microbial infection) Interacts with C.difficile toxin TcdB, suggesting that it may contribute to TcdB toxin entry into cells. It was however shown that NECTIN3/PVRL3 does not act as a major receptor for TcdB.
Subcellular location. Cell membrane. Postsynaptic cell membrane. Cell junction. Adherens junction.
Tissue specificity. Predominantly expressed in testis and placenta as well as in many cell lines, including epithelial cell lines.
Similarity. Belongs to the nectin family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NQS3-1 | 1 | yes |
| Q9NQS3-2 | 2 | |
| Q9NQS3-3 | 3 |
RefSeq proteins (3): NP_001230215, NP_001230217, NP_056295* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003599 | Ig_sub | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013106 | Ig_V-set | Domain |
| IPR013162 | CD80_C2-set | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR033319 | Nectin-3_IgV_dom | Domain |
| IPR033320 | IgC1_2_Nectin-3-4-like | Domain |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR051427 | Nectin/Nectin-like | Family |
Pfam: PF07686, PF08205
UniProt features (28 total): glycosylation site 6, sequence conflict 6, splice variant 4, disulfide bond 3, domain 3, topological domain 2, signal peptide 1, chain 1, sequence variant 1, transmembrane region 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4FOM | X-RAY DIFFRACTION | 3.93 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NQS3-F1 | 72.95 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 78–148, 193–246, 291–338
Glycosylation sites (6): 125, 186, 222, 331, 73, 83
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-418990 | Adherens junctions interactions |
| R-HSA-420597 | Nectin/Necl trans heterodimerization |
| R-HSA-1500931 | Cell-Cell communication |
| R-HSA-421270 | Cell-cell junction organization |
| R-HSA-446728 | Cell junction organization |
MSigDB gene sets: 268 (showing top):
GOBP_HETEROPHILIC_CELL_CELL_ADHESION, DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN, GOBP_SYNAPSE_ASSEMBLY, NKX25_02, GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, CAGCTG_AP4_Q5, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS, GOBP_CELL_CELL_ADHESION, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_CELL_JUNCTION_ORGANIZATION, GOBP_EAR_DEVELOPMENT, GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS, GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY, DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN
GO Biological Process (12): lens morphogenesis in camera-type eye (GO:0002089), homophilic cell-cell adhesion (GO:0007156), heterophilic cell-cell adhesion (GO:0007157), fertilization (GO:0009566), symbiont entry into host cell (GO:0046718), retina morphogenesis in camera-type eye (GO:0060042), establishment of protein localization to plasma membrane (GO:0061951), cochlea morphogenesis (GO:0090103), regulation of postsynapse assembly (GO:0150052), protein localization to cell junction (GO:1902414), cell adhesion (GO:0007155), cell-cell adhesion (GO:0098609)
GO Molecular Function (5): identical protein binding (GO:0042802), protein homodimerization activity (GO:0042803), cell adhesion molecule binding (GO:0050839), cell adhesion mediator activity (GO:0098631), protein binding (GO:0005515)
GO Cellular Component (13): plasma membrane (GO:0005886), cell-cell junction (GO:0005911), adherens junction (GO:0005912), axon (GO:0030424), dendrite (GO:0030425), apical junction complex (GO:0043296), cell-cell contact zone (GO:0044291), hippocampal mossy fiber to CA3 synapse (GO:0098686), postsynaptic density membrane (GO:0098839), membrane (GO:0016020), synapse (GO:0045202), postsynaptic membrane (GO:0045211), anchoring junction (GO:0070161)
Reactome top-level categories
Rollup of top-4 pathways:
| Category | Pathways |
|---|---|
| Cell-cell junction organization | 1 |
| Adherens junctions interactions | 1 |
| Cell junction organization | 1 |
| Cell-Cell communication | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell-cell junction | 3 |
| anatomical structure morphogenesis | 2 |
| camera-type eye morphogenesis | 2 |
| cell-cell adhesion | 2 |
| cell adhesion | 2 |
| protein binding | 2 |
| neuron projection | 2 |
| cell junction | 2 |
| lens development in camera-type eye | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| viral life cycle | 1 |
| symbiont entry into host | 1 |
| retina development in camera-type eye | 1 |
| establishment of protein localization to membrane | 1 |
| inner ear morphogenesis | 1 |
| embryonic morphogenesis | 1 |
| cochlea development | 1 |
| regulation of synapse assembly | 1 |
| postsynapse assembly | 1 |
| regulation of postsynapse organization | 1 |
| intracellular protein localization | 1 |
| cellular process | 1 |
| identical protein binding | 1 |
| protein dimerization activity | 1 |
| cell adhesion molecule binding | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| anchoring junction | 1 |
| dendritic tree | 1 |
| thorny excrescence | 1 |
| neuron to neuron synapse | 1 |
| hippocampal mossy fiber expansion | 1 |
| postsynaptic density | 1 |
| postsynaptic membrane | 1 |
| postsynaptic specialization membrane | 1 |
| cellular anatomical structure | 1 |
| synaptic membrane | 1 |
| postsynapse | 1 |
Protein interactions and networks
STRING
950 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NECTIN3 | AFDN | P55196 | 994 |
| NECTIN3 | TIGIT | Q495A1 | 994 |
| NECTIN3 | NECTIN2 | Q92692 | 953 |
| NECTIN3 | NECTIN1 | Q15223 | 869 |
| NECTIN3 | PVR | P15151 | 774 |
| NECTIN3 | SHROOM3 | Q8TF72 | 711 |
| NECTIN3 | PALS2 | Q9NZW5 | 703 |
| NECTIN3 | ACKR4 | Q9NPB9 | 684 |
| NECTIN3 | PVRIG | Q6DKI7 | 670 |
| NECTIN3 | CDH17 | Q12864 | 667 |
| NECTIN3 | CSPG4 | Q6UVK1 | 626 |
| NECTIN3 | MPP3 | Q13368 | 625 |
| NECTIN3 | CD96 | P40200 | 614 |
| NECTIN3 | CD226 | Q15762 | 610 |
| NECTIN3 | JAM3 | Q9BX67 | 608 |
IntAct
202 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NECTIN3 | NECTIN1 | psi-mi:“MI:0915”(physical association) | 0.840 |
| NECTIN1 | NECTIN3 | psi-mi:“MI:0915”(physical association) | 0.840 |
| NECTIN1 | NECTIN3 | psi-mi:“MI:0407”(direct interaction) | 0.840 |
| NECTIN2 | NECTIN3 | psi-mi:“MI:0915”(physical association) | 0.790 |
| NECTIN2 | NECTIN3 | psi-mi:“MI:0407”(direct interaction) | 0.790 |
| CD9 | ADAM10 | psi-mi:“MI:0914”(association) | 0.750 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| NOTCH2NLA | NECTIN3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| NECTIN3 | NOTCH2NLA | psi-mi:“MI:0915”(physical association) | 0.670 |
| AFDN | NECTIN3 | psi-mi:“MI:0915”(physical association) | 0.650 |
| NECTIN3 | TIGIT | psi-mi:“MI:0915”(physical association) | 0.610 |
| PVR | NECTIN3 | psi-mi:“MI:0915”(physical association) | 0.610 |
| NECTIN3 | PVR | psi-mi:“MI:0407”(direct interaction) | 0.610 |
| NECTIN3 | TIGIT | psi-mi:“MI:0407”(direct interaction) | 0.610 |
| NECTIN3 | PICK1 | psi-mi:“MI:0407”(direct interaction) | 0.590 |
| NECTIN3 | RGS20 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | NECTIN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NECTIN3 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | NECTIN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NECTIN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (134): PVRL3 (Two-hybrid), KRTAP4-2 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), NOTCH2NL (Two-hybrid), PVRL3 (Affinity Capture-MS), PVRL1 (Affinity Capture-MS), NPTX1 (Affinity Capture-MS), SDF2 (Affinity Capture-MS), ASPH (Affinity Capture-MS), FBXO2 (Affinity Capture-MS), COL14A1 (Affinity Capture-MS), MAK (Affinity Capture-MS)
ESM2 similar proteins: A0A0R4IGV4, A0A8M2B818, A0JM41, A2VD98, B0CLX4, B6ZK77, D3YX43, F1LW30, O00241, O18906, O54901, O88775, O95256, P00545, P04218, P0C673, P10522, P13369, P17948, P21995, P27931, P35916, P35917, P35969, P37301, P42071, P42703, P53767, Q08DK1, Q15762, Q58EG3, Q5DX21, Q5FWR8, Q5R412, Q5U2P2, Q5VJ70, Q6GMZ9, Q6PCB8, Q6X936, Q7TSN7
Diamond homologs: A0A8M2B818, B0JYH6, B4KPU0, P06731, P15151, P20273, P31997, P32506, P32507, Q15223, Q5FWR8, Q92692, Q9GL76, Q9JKF6, Q9JLB9, Q9N1E4, Q9N1E5, Q9N1E6, Q9NQS3, P41217, Q5ZPR3, Q7TPB4, Q8VE98, P28685, Q58EG3, Q5E9Z9, Q00889, Q8R007, Q96NY8, B3NS99, B4MR28, B4P5Q9, B4QC63, E1C8P7, O00533, P85171, Q0PMG2, Q4VA61, Q66KX2, Q6AWJ9
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 146 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 7 | 42.5× | 6e-08 |
| Assembly and cell surface presentation of NMDA receptors | 7 | 18.9× | 1e-05 |
| Neurexins and neuroligins | 9 | 18.9× | 2e-07 |
| Protein-protein interactions at synapses | 6 | 16.9× | 8e-05 |
| RHOQ GTPase cycle | 6 | 11.6× | 6e-04 |
| RAF/MAP kinase cascade | 7 | 4.5× | 7e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 9 | 41.2× | 5e-10 |
| protein localization to synapse | 6 | 36.2× | 3e-06 |
| receptor clustering | 7 | 34.4× | 4e-07 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 6 | 23.4× | 3e-05 |
| establishment of protein localization | 5 | 17.0× | 9e-04 |
| establishment of cell polarity | 5 | 15.1× | 1e-03 |
| bicellular tight junction assembly | 5 | 13.0× | 2e-03 |
| Ras protein signal transduction | 6 | 9.7× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 8 |
| Benign | 16 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
954 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:111071905:G:GT | donor_gain | 1.0000 |
| 3:111118654:A:AG | acceptor_gain | 1.0000 |
| 3:111118654:AGTT:A | acceptor_gain | 1.0000 |
| 3:111118655:G:GG | acceptor_gain | 1.0000 |
| 3:111118655:GTT:G | acceptor_gain | 1.0000 |
| 3:111118655:GTTG:G | acceptor_gain | 1.0000 |
| 3:111118951:GT:G | donor_gain | 1.0000 |
| 3:111122115:TTATA:T | acceptor_loss | 1.0000 |
| 3:111122117:ATAG:A | acceptor_loss | 1.0000 |
| 3:111122119:AGA:A | acceptor_loss | 1.0000 |
| 3:111122120:GAT:G | acceptor_gain | 1.0000 |
| 3:111122234:AGCAG:A | donor_loss | 1.0000 |
| 3:111122235:GCAG:G | donor_gain | 1.0000 |
| 3:111122236:CAGGT:C | donor_loss | 1.0000 |
| 3:111122237:AGGTA:A | donor_loss | 1.0000 |
| 3:111122238:GG:G | donor_loss | 1.0000 |
| 3:111122240:T:A | donor_loss | 1.0000 |
| 3:111126333:CAGGT:C | donor_loss | 1.0000 |
| 3:111126335:GGTA:G | donor_loss | 1.0000 |
| 3:111126336:G:GG | donor_gain | 1.0000 |
| 3:111133621:ACT:A | acceptor_gain | 1.0000 |
| 3:111133623:T:A | acceptor_gain | 1.0000 |
| 3:111071902:C:G | donor_gain | 0.9900 |
| 3:111112225:G:T | donor_gain | 0.9900 |
| 3:111118651:AACAG:A | acceptor_loss | 0.9900 |
| 3:111118652:ACAGT:A | acceptor_loss | 0.9900 |
| 3:111118653:CAGTT:C | acceptor_loss | 0.9900 |
| 3:111118654:A:AC | acceptor_loss | 0.9900 |
| 3:111118655:GT:G | acceptor_gain | 0.9900 |
| 3:111118655:GTTGA:G | acceptor_gain | 0.9900 |
AlphaMissense
3565 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:111112140:T:A | W91R | 1.000 |
| 3:111112140:T:C | W91R | 1.000 |
| 3:111112142:G:C | W91C | 1.000 |
| 3:111112142:G:T | W91C | 1.000 |
| 3:111112311:T:A | C148S | 1.000 |
| 3:111112312:G:C | C148S | 1.000 |
| 3:111118730:T:A | C193S | 1.000 |
| 3:111118730:T:C | C193R | 1.000 |
| 3:111118731:G:A | C193Y | 1.000 |
| 3:111118731:G:C | C193S | 1.000 |
| 3:111118732:C:G | C193W | 1.000 |
| 3:111118769:T:A | W206R | 1.000 |
| 3:111118769:T:C | W206R | 1.000 |
| 3:111118771:G:C | W206C | 1.000 |
| 3:111118771:G:T | W206C | 1.000 |
| 3:111118889:T:C | C246R | 1.000 |
| 3:111122127:C:A | P269H | 1.000 |
| 3:111122187:T:C | L289P | 1.000 |
| 3:111122192:T:A | C291S | 1.000 |
| 3:111122192:T:C | C291R | 1.000 |
| 3:111122193:G:C | C291S | 1.000 |
| 3:111122231:T:A | W304R | 1.000 |
| 3:111122231:T:C | W304R | 1.000 |
| 3:111122233:G:C | W304C | 1.000 |
| 3:111122233:G:T | W304C | 1.000 |
| 3:111126272:T:G | Y336D | 1.000 |
| 3:111126278:T:A | C338S | 1.000 |
| 3:111126279:G:C | C338S | 1.000 |
| 3:111126292:T:A | N342K | 1.000 |
| 3:111126292:T:G | N342K | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000001747 (3:111114520 G>A,C), RS1000081016 (3:111096754 T>A,C), RS1000082548 (3:111137180 C>T), RS1000101676 (3:111157182 C>G), RS1000141057 (3:111072766 G>A,T), RS1000149126 (3:111102321 T>C), RS1000167571 (3:111119919 T>C), RS1000175912 (3:111079160 T>C), RS1000190830 (3:111144239 T>G), RS1000203369 (3:111102106 A>G), RS1000257660 (3:111163317 A>G), RS1000281041 (3:111150031 T>G), RS1000283150 (3:111119728 A>C,G), RS1000288593 (3:111084950 G>A,T), RS1000332291 (3:111150294 A>G)
Disease associations
OMIM: gene MIM:607147 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002759_1 | Motion sickness | 4.000000e-44 |
| GCST003447_3 | Neuroticism | 4.000000e-08 |
| GCST006951_40 | Feeling hurt | 3.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006928 | motion sickness |
| EFO:0007660 | neuroticism measurement |
| EFO:0009599 | feeling emotionally hurt measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, decreases methylation | 4 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression, affects methylation | 3 |
| Arsenic | affects methylation, affects cotreatment, increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases reaction, increases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| monomethylarsonous acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Lipopolysaccharides | increases expression, decreases reaction | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Ouabain | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B8LC | Abcam HCT 116 NECTIN3 KO | Cancer cell line | Male |
| CVCL_B9NI | Abcam A-549 NECTIN3 KO | Cancer cell line | Male |
| CVCL_D2GN | Abcam MCF-7 NECTIN3 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.